1)服部行紀,松原亜季子,関根茂樹,他.十二指腸の腫瘍・腫瘍様病変の病理診断—腫瘍様上皮性病変とそれら由来の腫瘍の病理学的特徴.胃と腸 46:1596-1603, 2011
2)九嶋亮治.十二指腸非乳頭部における腫瘍様病変と腫瘍の組織発生.日消誌 115:160-167, 2018
3)Mitsuishi T, Hamatani S, Hirooka S, et al. Clinicopathological characteristics of duodenal epithelial neoplasms:focus on tumors with a gastric mucin phenotype(pyloric gland-type tumors). PLoS One 12:e0174985, 2017
4)Vieth M, Kushima R, Mukaisho K, et al. Immunohistochemical analysis of pyloric gland adenomas using a series of Mucin 2, Mucin 5AC, Mucin 6, CD10, Ki67 and p53. Virchows Arch 457:529-536, 2010
5)Matsuo Y, Yamamoto H, Sato Y, et al. GNAS-mutated carcinoma arising from gastric foveolar metaplasia in the duodenum after 9 years of observation. Clin J Gastroenterol 11:391-395, 2018
6)Niwa A, Kuwano S, Tomita H, et al. The different pathogeneses of sporadic adenoma and adenocarcinoma in non-ampullary lesions of the proximal and distal duodenum. Oncotarget 8:41078-41090, 2017
7)Matsubara A, Sekine S, Kushima R, et al. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J Pathol 229:579-587, 2013
8)Pezhouh MK, Park JY. Gastric pyloric gland adenoma. Arch Pathol Lab Med 139:823-826, 2015
9)Vieth M, Kushima R, Borchard F, et al. Pyloric gland adenoma:a clinico-pathological analysis of 90 cases. Virchows Arch 442:317-321, 2003
10)Chen ZM, Scudiere JR, Abraham SC, et al. Pyloric gland adenoma:an entity distinct from gastric foveolar type adenoma. Am J Surg Pathol 33:186-193, 2009
11)田邉寛,岩下明德,原岡誠司,他.十二指腸の腫瘍・腫瘍様病変の病理診断—腺腫と癌の診断基準と臨床病理学的特徴.胃と腸 46:1587-1595, 2011
12)Ushiku T, Arnason T, Fukayama M, et al. Extra-ampullary duodenal adenocarcinoma. Am J Surg Pathol 38:1484-1493, 2014
13)Minatsuki C, Yamamichi N, Inada KI, et al. Expression of gastric markers is associated with malignant potential of nonampullary duodenal adenocarcinoma. Dig Dis Sci 63:2617-2625, 2018
14)九嶋亮治,服部隆則.増殖動態と分化マーカーからみた胃腺腫と腺癌の鑑別.病理と臨 16:17-23, 1998
15)菅井有,幅野渉,上杉憲幸,他.胃腺腫と腫瘍グレードに基づいた分化型粘膜内胃癌の臨床病理学的および分子病理学的解析.胃と腸 47:203-216, 2012
16)具嶋亮介,八尾隆史.胃腺腫と分化型腺癌との病理学的鑑別—腸型腺腫.胃と腸 49:1827-1836, 2014
17)Minematsu H, Saito Y, Kakinoki R, et al. Evaluation of mucin expression patterns in gastric borderline(group III)lesions. J Gastroenterol 41:547-553, 2006
18)Gushima R, Yao T, Kurisaki-Arakawa A, et al. Expression of adipophilin in gastric epithelial neoplasia is associated with intestinal differentiation and discriminates between adenoma and adenocarcinoma. Virchows Arch 468:169-177, 2016
19)Kolodziejczyk P, Yao T, Oya M, et al. Long term follow-up study of patients with gastric adenomas with malignant transformation An immunohistochemical and histochemical analysis. Cancer 74:2896-2907, 1994
20)渕上忠彦,岩下明德,堺勇二,他.胃良・悪性境界病変(Group III病変)の長期経過からみた生検診断の問題点.胃と腸 29:153-168, 1994
21)大屋正文,八尾隆史,恒吉正澄.胃sm癌の深達度と粘液形質および癌関連遺伝子産物の発現.胃と腸 32:31-39, 1997
22)田邉寛,岩下明德,原岡誠司,他.転移を来した胃粘膜内癌の特徴—病理形態学的な立場から.胃と腸 41:1119-1129, 2006
23)九嶋亮治,向所賢一,塚下しづき,他.胃型分化型早期胃癌の分子生物学的特徴.胃と腸 38:707-721, 2003
24)八尾隆史,仲程純,山城雄也,他.胃型形質の低異型度分化型胃癌の頻度と臨床病理学的特徴.胃と腸 53:9-15, 2018
25)Yao T, Wada R. Pathology of gastric cancer. In Shiotani A(ed).Gastric Cancer:With Special Focus on Studies from Japan. Springer, New York, pp 63-75, 2019
26)津山翔,八尾隆史.十二指腸上皮性非乳頭部腫瘍の臨床病理と分子生物学を巡って—臨床病理概論.臨消内科 33:1217-1224, 2018
27)Hida R, Yamamoto H, Hirahashi M, et al. Duodenal neoplasms of gastric phenotype:an immunohistochemical and genetic study with a practical approach to the classification. Am J Surg Pathol 41:343-353, 2017